Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis

Journal of Applied Physiology

Volumn 87, Issue 1, 1999, Pages 438-443

  Roum, James H ^a,e   Borok, Zea ^a,c   McElvaney, Noel G ^a   Grimes, George J ^b   Bokser, Allan D ^b   Buhl, Roland ^a   Crystal, Ronald G ^a,d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Bronchoalveolar lavage; Neutrophil; Respiratory epithelium; Superoxide anion

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; OXIDIZING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; THORAX RADIOGRAPHY;

EID: 0032779834     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.87.1.438     Document Type: Article

References (44)

1. Birrer, P., N. G. McElvaney, A. Rudeberg, C. W. Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150: 207-213, 1994.
2. Borok, Z., R. Buhl, G. J. Grimes, A. D. Bokser, R. C. Hubbard, K. J. Holroyd, J. H. Roum, D. B. Czerski, A. M. Cantin, and R. G. Crystal. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338: 215-216, 1991.
3. 1-proteinase inhibitor by N-acetyl cysteine, glutathione, and methionine. Agents Actions 22: 255-260, 1987.
4. Buhl, R., C. Vogelmeier, M. Critenden, R. C. Hubbard, R. F. Hoyt, Jr., E. M. Wilson, A. M. Cantin, and R. G. Crystal. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc. Natl. Acad. Sci. USA 87: 4063-4067, 1990.
5. Bunnell, E., and E. R. Pacht. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148: 1174-1178, 1993.
6. Buret, A., and A. W. Cripps. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am. Rev. Respir. Dis. 148: 793-805, 1993.
7. Cantin, A. M., R. C. Hubbard, and R. G. Crystal. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139: 370-372, 1989.
8. Cantin, A. M., S. L. North, G. A. Fells, R. C. Hubbard, and R. G. Crystal. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79: 1665-1673, 1987.
9. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63: 152-157, 1987.
10. 2. Blood 69: 493-500, 1987.
11. Davis, W. B., and E. R. Pacht. Extracellular antioxidant defenses. In: The Lung: Scientific Foundations (2nd ed.), edited by R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes. Philadelphia, PA: Lippincott-Raven, 1997, p. 2271-2278.
12. Elborn, J. S., and D. J. Shale. Cystic fibrosis. 2. Lung injury in cystic fibrosis. Thorax 45: 970-973, 1990.
13. Fulmer, J. D., W. C. Roberts, E. R. von Gal, and R. G. Crystal. Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J. Clin. Invest. 60: 595-610, 1977.
14. Holland, S. M., and J. I. Gallin. Neutrophils. In: The Lung: Scientific Foundations (2nd ed.), edited by R. G. Crystal, J. B. West, E. R. Weibel and P. J. Barnes. Philadelphia, PA: Lippincott-Raven, 1997, p. 877-890.
15. 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 80: 1289-1295, 1987.
16. Kerem, B., J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L. C. Tsui. Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080, 1989.
17. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150: 448-454, 1994. [Corrigenda. Am. J. Respir. Crit. Care Med. 151: January 1995, p. 260.]
18. Li, X. Y., K. Donaldson, I. Rahman, and W. MacNee. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am. J. Respir. Crit. Care Med. 149: 1518-1525, 1994.
19. MacNee, W., M. M. Bridgeman, M. Marsden, E. Drost, S. Lannan, C. Selby, and K. Donaldson. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells. Am. J. Med. 91: 60S-66S, 1991.
20. 1-antitrypsin treatment for cystic fibrosis. Lancet 337: 392-394, 1991.
21. Meister, A., and M. E. Anderson. Glutathione. Annu. Rev. Biochem. 52: 711-760, 1983.
22. 1-protease inhibitor: role of lipid peroxidation products. J. Appl. Physiol. 66: 2211-2215, 1989.
23. Oliver, J. M., S. P. Spielberg, C. B. Pearson, and J. D. Schulman. Microtubule assembly and function in normal and glutathione synthetase-deficient polymorphonuclear leukocytes. J. Immunol. 120:1181-1186, 1978.
24. Pacht, E. R., A. P. Timerman, M. G. Lykens, and A. J. Merola. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100: 1397-1403, 1991.
25. 1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem. Biol. Interact. 57: 271-283, 1986.
26. Rajkovic, I. A., and R. Williams. Enhancement of neutrophil response by SH-containing compounds: modulation of superoxide and hydrogen peroxide production. Biochem. Pharmacol, 33: 1249-1256, 1984.
27. Rajkovic, I. A., and R. Williams. Inhibition of neutrophil function by hydrogen peroxide. Effect of SH-group-containing compounds. Biochem. Pharmacol. 34: 2083-2090, 1985.
28. Rennard, S. I., G. Basset, D. Lecossier, K. M. ODonnell, P. Pinkston, P. G. Martin, and R. G. Crystal. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60: 532-538, 1986.
29. Riordan, J. R. The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55: 609-630, 1993.
30. Riordan, J. R., J. M. Rommens, B.-S. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J. L. Chou, M. L. Drumm, M. Ianuzzi, F. S. Collins, and L.-C. Tsui. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
31. Rommens, J. M., M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J. L. Cole, D. Kennedy, N. Hidaka, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065, 1989.
32. Roos, D., R. S. Weening, A. A. Voetman, M. L. van Schaik, A. A. Bot, L. J. Meerhof, and J. A. Loos. Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency. Blood 53: 851-866, 1979.
33. Rosenberg, S. M., W. F. Howatt, and C. M. Grum. Spirometry and chest roentgenographic appearance in adults with cystic fibrosis. Chest 101: 961-964, 1992.
34. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143-155, 1992.
35. Roum, J. H., R. Buhl, N. G. McElvaney, Z. Borok, and R. G. Crystal. Systemic deficiency of glutathione in cystic fibrosis. J. Appl. Physiol. 75: 2419-2424, 1993.
36. Saltini, C., A. J. Hance, V. J. Ferrans, F. Basset, P. B. Bitterman, and R. G. Crystal. Accurate quantification of cells recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 130: 650-658, 1984.
37. Seybold, Z. V., W. M. Abraham, H. Gazeroglu, and A. Wanner. Impairment of airway mucociliary transport by Pseudomonas aeruginosa products. Role of oxygen radicals. Am. Rev. Respir. Dis. 146: 1173-1176, 1992.
38. 2: dependence on phenotype and catalase. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L318-L325, 1991.
39. Spielberg, S. P., L. A. Boxer, J. M. Oliver, J. M. Allen, and J. D. Schulman. Oxidative damage to neutrophils in glutathione synthetase deficiency. Br. J. Haematol. 42: 215-223, 1979.
40. 1-protease inhibitor. J. Biol. Chem. 266: 5279-5285, 1991.
41. Warren, J. S., and P. A. Ward. Consequences of oxidant injury. In: The Lung: Scientific Foundations (2nd ed.), edited by R. G. Crystal, J. B. West, E. R. Weibel and P. J. Barnes. Philadelphia, PA: Lippincott-Raven, 1997, p. 2279-2288.
42. Weiss, S. J. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376, 1989.
43. Welsh, M. J., L.-C. Tsui, T. F. Boat, and A. L. Beaudet. Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Diseases (7th ed.), edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. New York: McGraw-Hill, 1995, p. 3799-3876.
44. Wendel, A., and P. Cikryt. The level and half-life of glutathione in human plasma. FEBS Lett. 120: 209-211, 1980.